SERT x 5-HT1D receptor x σ1 receptor x 5-HT2C receptor x 5-HT2A receptor - 药物、适应症、专利

A Phase 1, Single-Center, Repeat-Dose, Open-Label, Fixed-Sequence Drug-Drug Interaction Study of ZX008 in Healthy Male Or Female Study Participants 18 To 55 Years Of Age

The purpose of the study is to assess the single-dose pharmacokinetics (PK) of 3 probe drugs (midazolam, bupropion, and metformin) before and after repeat doses of ZX008

开始日期2024-12-04

申办/合作机构

UCB BioSciences, Inc.

100 项与 SERT x 5-HT1D receptor x σ1 receptor x 5-HT2C receptor x 5-HT2A receptor 相关的临床结果

登录后查看更多信息

100 项与 SERT x 5-HT1D receptor x σ1 receptor x 5-HT2C receptor x 5-HT2A receptor 相关的转化医学

登录后查看更多信息

0 项与 SERT x 5-HT1D receptor x σ1 receptor x 5-HT2C receptor x 5-HT2A receptor 相关的专利（医药）

登录后查看更多信息

分析

对领域进行一次全面的分析。

登录

或

查看完整样例数据